Trial Profile
Translational Neuropsychopharmacology Research of Nicotine Addiction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2022
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary) ; Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Pharmacodynamics
- 07 Jul 2020 Status changed from active, no longer recruiting to completed.
- 29 Jun 2020 Status changed from recruiting to active, no longer recruiting.
- 29 Jan 2018 Status changed to recruiting.